AI-generated analysis. Always verify with the original filing.
Infleqtion, Inc., a quantum technology company developing sensing, computing, and software platforms using neutral atoms, completed a reverse merger with SPAC Churchill Capital Corp X in February 2026, becoming publicly traded on NYSE under INFQ. This S-1 registers resale of 121.8M shares and 75K private warrants by selling securityholders, with up to $119.9M potential proceeds from warrant exercises for general corporate purposes.
Infleqtion operates at the forefront of quantum technology, leveraging a neutral atom platform to develop full-stack solutions spanning sensing (Tiqker clocks, Sqywire RF sensors), computing (Sqale system with 12 logical qubits), and software (Superstaq, CML). This vertically integrated approach enables room-temperature scalability and high fidelity (99.73% CZ gate), positioning it for quantum advantage across defense, AI, energy, and space applications. Revenue reached $32.5M in 2025 (13% YoY growth), driven 81% by U.S./UK government contracts, but persistent losses ($31.8M net loss, $231M accumulated deficit) reflect heavy R&D investment ($24.1M) amid scaling challenges. Cash burn moderated to $24.1M from $32.5M YoY, supported by $100M Series C raise, but liquidity ($11.9M cash + $51.5M securities) underscores need for post-merger $551M infusion.
The February 2026 SPAC merger with Churchill Capital Corp X (ticker INFQ) valued Legacy Infleqtion at $1.8B pre-money, issuing 216.5M shares with Infleqtion holders at 70.1% ownership. PIPE added $126.5M; Sponsor holds 5% (with 1.5M vesting shares tied to $12 VWAP trigger). This S-1 enables resale of 121.8M shares (56% float) by insiders/early investors, potentially pressuring near-term price amid lockups expiring 180 days post-close or $12 VWAP trigger. Warrant exercises could yield $119.9M at $11.50/strike for corporate purposes, but dilution risk looms with 10.4M public warrants outstanding.
Risks center on technology immaturity—quantum advantage unproven at scale, with 100 logical qubits targeted for 2028 amid competition from IonQ, IBM, Rigetti. Government reliance (60% U.S., 12% UK) exposes to budget volatility; expired UK contracts cut revenue but were offset. Material weaknesses in controls (segregation, equity tracking) persist, with remediation into 2027. IP from university licenses (CU, Wisconsin) critical but terminable. Management blends VC (CEO Kinsella), tech (CFO Hart ex-Intel/Zoox), quantum expertise (CTO Gokhale).
Investor implications: High-upside quantum play with deployed sensing revenue and computing roadmap, but execution risks dominate. Post-merger liquidity bolsters runway, yet profitability distant amid $25M+ SG&A. Neutral atom moat promising, but market skepticism on timelines could cap valuation.
Offering Amount
$1.22B
Shares Offered
1,400,000,000
Price Range
$0.23 – $0.58
Share Type
Common Stock
Exchange
NYSE
Ticker
INFQ
Use of Proceeds: Net proceeds from warrant exercises for general corporate purposes.
Develops and commercializes quantum technology products including quantum sensing, quantum computing and software on neutral atom platform for defense, AI, energy, space, materials discovery and cybersecurity.